Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Oxygen 💬 1件: Oxygen3件: Medical air; Nitrogen; Oxygen; --13件: 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬
2 Oxiglutatione 💬 1件: Glutathione2件: GLUTATHIONE; Reduced glutathione; --2件: 6, 299 💬
3 Oxytocin 💬 1件: Oxytocin2件: OXYTOCIN; Syntocinon; 1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬7件: 6, 72, 127, 168, 193, 206, 226 💬
4 Octreotide 💬 1件: Octreotide3件: Octreotide; OCTREOTIDE ACETATE; Sandostatin LAR; 1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 67, 75, 84, 85, 89, 193, 227 💬
5 Olanzapine 💬 1件: Olanzapine2件: OLANZAPINE; Zyprexa; 11件: ADRA1A,
ADRA1B,
ADRA1D,
DRD2,
DRD3,
DRD4,
HRH1,
HTR2A,
HTR2B,
HTR2C,
HTR6 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 8 💬
6 Omeprazole 💬 1件: Omeprazole4件: Losec; Omeprazol; Omeprazole; OMEPRAZOLE MAGNESIUM; 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬
7 Ondansetron 💬 1件: Ondansetron1件: Ondansetron; 5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬		2件: Serotonergic synapse, Taste transduction 💬3件: 6, 97, 107 💬
8 Oxandrolone 💬 1件: Oxandrolone1件: Oxandrolone; 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 211, 285 💬
9 Oxybutynin 💬 1件: Oxybutynin1件: Oxybutynin; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 13, 53 💬
10 Oxcarbazepine 💬 1件: Oxcarbazepine2件: Oxcarbazepine; Trileptal; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
11 Oxatomide 💬 1件: Oxatomide1件: Oxatomide; 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113 💬
12 Oleic acid 💬 1件: Oleic Acid1件: Oleic Acid; --2件: 13, 299 💬
13 Olive oil 💬 1件: Olive oil1件: Olive oil; --5件: 13, 35, 49, 53, 162 💬
14 Ocrelizumab 💬 1件: Ocrelizumab3件: Ocrelizumab; OCREVUS; RhuMAb 2H7; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
15 Omalizumab 💬 1件: Omalizumab2件: OMALIZUMAB; Xolair; 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299 💬
16 Oprelvekin 💬 1件: Oprelvekin5件: IL-11; Interleukin 11; Interleukin-11; Oprelvekin; Recombinant interleukin-11; 1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬2件: 96, 288 💬
17 Oxycodone 💬 1件: Oxycodone2件: Oxycodone; OXYCODONE HYDROCHLORIDE; 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 13, 70, 226, 298 💬
18 Oxyquinoline 💬 1件: Oxyquinoline1件: Oxine; --1件: 13 💬
19 Olsalazine 💬 1件: Olsalazine1件: Olsalazine; --1件: 271 💬
20 Ornithine 💬 1件: Ornithine1件: Ornithine; --2件: 245, 251 💬
21 Oseltamivir 💬 1件: Oseltamivir1件: Oseltamivir; --2件: 97, 299 💬
22 Oxiconazole 💬 1件: Oxiconazole1件: Oxiconazole; --1件: 160 💬
23 Oxybuprocaine 💬 1件: Oxybuprocaine1件: Oxybuprocaine; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
24 Oxymorphone 💬 1件: Oxymorphone1件: Opana; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
25 Otelixizumab 💬 1件: Otelixizumab1件: Otelixizumab; 3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 46 💬
26 Ofatumumab 💬 1件: Ofatumumab4件: Arzerra; HuMax-CD20; Kesimpta; OFATUMUMAB; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 35, 46 💬
27 Obinutuzumab 💬 1件: Obinutuzumab2件: Gazyvaro; Obinutuzumab; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬4件: 43, 44, 49, 222 💬
28 Obeticholic acid 💬 1件: Obeticholic acid4件: 6-ECDCA; 6-ethylchenodeoxycholic acid; OBETICHOLIC ACID; Ocaliva; 1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296 💬
29 Omadacycline 💬 1件: Omadacycline1件: Omadacycline; --1件: 299 💬
30 Orvepitant 💬 1件: Orvepitant1件: ORVEPITANT; 1件: TACR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 85 💬
31 Olaparib 💬 1件: Olaparib1件: Olaparib; 2件: PARP1,
PARP2 💬		5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬2件: 86, 285 💬
32 Ozoralizumab 💬 1件: Ozoralizumab1件: Ozoralizumab; 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
33 Ozanezumab 💬 1件: Ozanezumab1件: Ozanezumab; 1件: RTN4 💬1件: Alzheimer disease 💬1件: 2 💬
34 Olipudase alfa 💬 1件: Olipudase alfa1件: OLIPUDASE ALFA; 1件: SMPD1 💬5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
35 Opicapone 💬 1件: Opicapone2件: Ongentys; OPICAPONE; 1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
36 Omaveloxolone 💬 1件: Omaveloxolone1件: Omaveloxolone; 1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
37 Ozanimod 💬 1件: Ozanimod2件: OZANIMOD; Zeposia; 5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
38 Osilodrostat 💬 1件: Osilodrostat1件: OSILODROSTAT; 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
39 Olesoxime 💬 1件: Olesoxime1件: Olesoxime; --3件: 2, 3, 13 💬
40 Otilimab 💬 1件: Otilimab1件: OTILIMAB; 1件: CSF2 💬16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬1件: 46 💬
41 Obexelimab 💬 1件: Obexelimab1件: Obexelimab; 1件: CD19 💬5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬1件: 300 💬
42 Onasemnogene abeparvovec 💬 1件: Onasemnogene abeparvovec3件: ONASEMNOGENE ABEPARVOVEC; Onasemnogene Abeparvovec-xioi; Zolgensma; 1件: SMN1 💬1件: 💬1件: 3 💬
43 Odevixibat 💬 1件: Odevixibat1件: Odevixibat; 1件: SLC10A2 💬1件: Bile secretion 💬3件: 296, 297, 338 💬
44 Opicinumab 💬 1件: Opicinumab1件: Opicinumab; 1件: LINGO1 💬1件: 💬1件: 13 💬
45 Orilanolimab 💬 1件: Orilanolimab1件: ORILANOLIMAB; 1件: FCGRT 💬1件: 💬1件: 61 💬
46 Orelabrutinib 💬 1件: Orelabrutinib1件: Orelabrutinib; 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬4件: 13, 49, 61, 63 💬
47 Olokizumab 💬 1件: Olokizumab1件: Olokizumab; 1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬2件: 46, 96 💬